ACE-031 1mg

ACE-031 1 mg is a high-purity lyophilized peptide research compound supplied exclusively for scientific investigation and controlled laboratory experimentation. For research use only — not for human or veterinary use.  

Product Overview

ACE-031 is a synthetic protein-based research compound developed for advanced laboratory investigations involving molecular signalling, ligand-receptor interactions and regulatory pathway research. Its defined molecular characteristics have attracted scientific interest within experimental biochemical research, where investigators continue to explore complex molecular interactions and signalling mechanisms under carefully controlled laboratory conditions. This preparation contains 1 mg of lyophilized ACE-031 supplied in a sealed research vial. Independent analytical testing measured an assay content of 0.922 mg for this production batch. Chromatographic analysis confirmed 99.6 percent purity, while identity was independently evaluated through FTIR spectrum analysis, retention time confirmation and molecular ion mass identification. Microbiological testing reported 0 CFU/g for both total aerobic microbial count and total yeast and mold count, while bacterial endotoxin analysis returned a result of 0.100 EU/mg. Comprehensive elemental impurity screening additionally reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. With its defined molecular identity, reproducible analytical profile and comprehensive third-party verification, ACE-031 provides researchers with a well-characterised research material suitable for advanced molecular investigations and controlled in vitro laboratory studies.  

Compound Overview

ACE-031 is a research compound commonly utilised in laboratory investigations involving molecular biology, ligand interactions and cellular signalling systems. Researchers employ ACE-031 in controlled experimental models designed to investigate molecular interactions, signalling pathways and complex biochemical regulatory systems. Its defined analytical characteristics allow identity and quality parameters to be evaluated using complementary chromatographic, spectroscopic and mass spectrometric techniques. These analytical methods provide researchers with independent information regarding assay content, purity and molecular identity for individual production batches. Today, ACE-031 continues to form part of experimental molecular research involving biochemical signalling and controlled in vitro investigations.  

Historical Background and Scientific Context

Advances in molecular biology and analytical chemistry have enabled researchers to develop and characterise increasingly sophisticated research compounds for investigating ligand-receptor interactions and cellular signalling mechanisms. Modern experimental models allow investigators to examine complex regulatory pathways under carefully controlled laboratory conditions. Analytical technologies including ultra-high-performance liquid chromatography, FTIR identification and mass spectrometry have significantly improved the ability to verify compound identity, purity and manufacturing consistency. These analytical techniques can be complemented by bacterial endotoxin testing, microbiological analysis and elemental impurity screening to provide comprehensive batch-specific documentation. ACE-031 remains part of this broader field of investigational compounds utilised exclusively for scientific research and controlled in vitro experimentation.  

Mechanistic Focus in Research

Within controlled laboratory environments, ACE-031 may be investigated in relation to molecular signalling, ligand interactions and cellular regulatory pathways. Research investigations frequently explore:

• Ligand-receptor interaction research
• Molecular signalling pathways
• Intracellular molecular communication
• Cellular regulatory mechanisms
• Biochemical pathway analysis
• Protein interaction research
• Comparative molecular investigations
• Controlled in vitro studies

These experimental models allow researchers to investigate molecular signalling mechanisms while maintaining carefully controlled laboratory conditions.  

Analytical Verification (COA)

Each batch of ACE-031 supplied by Grail Formula undergoes comprehensive independent third-party laboratory verification to confirm identity, assay content, purity and microbiological quality. Analytical testing for this batch was performed by Liquilabs s.r.o. Czechia using chromatographic, spectrometric, microbiological and mass spectrometry techniques. Batch: GF-HACE1-B241

• Assay Content: 0.922 mg
• Purity: 99.6 %
• Identification by FTIR Spectrum: 995
• Identification by Retention Time: 0.997
• Molecular Ion Mass Identification: 2956 Da
• Bacterial Endotoxins: 0.100 EU/mg
• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g

Independent peptide screening measured an assay content of 0.922 mg with a reported analytical uncertainty of ±0.005 mg. Purity analysis confirmed 99.6 percent purity with a reported analytical uncertainty of ±0.5 percent. Identity was evaluated through FTIR spectrum analysis with a reported result of 995 and retention time analysis with a result of 0.997. Mass spectrometry identified a molecular ion mass of 2956 Da with a reported analytical uncertainty of ±1 Da, providing an additional independent identity parameter for the tested material. Bacterial endotoxin testing returned a result of 0.100 EU/mg. Microbiological testing reported 0 CFU/g for total aerobic microbial count and 0 CFU/g for total yeast and mold count. Independent elemental impurity analysis reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. These analytical procedures provide independent confirmation of identity, purity, traceability and important batch-specific laboratory quality parameters.  

Research Applications

Within controlled laboratory environments, ACE-031 may be utilised in experimental models designed to investigate molecular signalling, ligand interactions and biochemical regulatory mechanisms. Examples of research applications include:

• Ligand-receptor interaction investigations
• Molecular signalling research
• Intracellular signalling investigations
• Cellular regulatory pathway analysis
• Biochemical interaction studies
• Protein interaction research
• Comparative molecular investigations
• Controlled in vitro laboratory studies

These applications are intended exclusively for scientific and laboratory investigation.  

Grail Formula Quality

Every Grail Formula research compound is supported by comprehensive independent analytical verification and transparent batch-specific laboratory documentation. Each production batch undergoes extensive testing to verify:

• Compound identity confirmation
• Assay content verification
• Purity assessment
• Molecular ion mass verification
• Retention time confirmation
• FTIR spectrum identification
• Endotoxin analysis
• Microbial contamination screening
• Elemental impurity screening
• Complete batch traceability

Independent laboratory testing helps provide researchers with reliable, reproducible and transparently documented research material suitable for advanced scientific investigation.  

When You Choose Grail Formula

When selecting Grail Formula, researchers receive independently verified research compounds supported by complete Certificates of Analysis and transparent batch-specific laboratory documentation. Our analytical verification programme includes assay determination, purity confirmation, FTIR spectrum identification, retention time verification, molecular ion mass identification, endotoxin screening, microbiological analysis and comprehensive elemental impurity testing. Every production batch is accompanied by a downloadable Certificate of Analysis issued by Liquilabs s.r.o. Czechia, providing complete traceability, independent verification and confidence in the analytical quality of every research compound supplied.  

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.6 % purity confirmed by COA
• Assay content verified at 0.922 mg
• Identification confirmed by FTIR spectrum and retention time analysis
• Molecular ion mass identified at 2956 Da
• Bacterial endotoxin level of 0.100 EU/mg
• No detectable heavy metals or microbial contamination
• Research-grade compound
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.